Biomonitoring equivalents for perfluorooctanoic acid (PFOA) for the interpretation of biomonitoring data
Background: Perfluorooctanoic acid (PFOA) is detected in the blood of virtually all biomonitoring study participants. Assessing health risks associated with blood PFOA levels is challenging because exposure guidance values (EGVs) are typically expressed in terms of external dose. Biomonitoring equiv...
Main Authors: | Ernest-Louli Tewfik, Nolwenn Noisel, Marc-André Verner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Environment International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0160412023004439 |
Similar Items
-
Perfluorooctanoic acid (PFOA) exposure in relation to the kidneys: A review of current available literature
by: Dongge Liu, et al.
Published: (2023-01-01) -
Insight into the Impacts and Removal Pathways of Perfluorooctanoic Acid (PFOA) in Anaerobic Digestion
by: Hongyu Xie, et al.
Published: (2022-07-01) -
Maternal concentrations of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) and duration of breastfeeding
by: Chunyuan Fei, et al.
Published: (2010-09-01) -
Perfluorooctanoic acid (PFOA) induces behavioural, reproductive and developmental toxicological impacts in Caenorhabditis elegans at concentrations relevant to the contaminated areas
by: Tanmoy Sana, et al.
Published: (2021-07-01) -
Evaluation of perfluorooctanoate for potential genotoxicity
by: John L. Butenhoff, et al.
Published: (2014-01-01)